| 原文 | 英語 |
|---|---|
| 主出版物標題 | Recent Advances in Cancer Research and Therapy |
| 發行者 | Elsevier Inc. |
| 頁面 | 351-369 |
| 頁數 | 19 |
| ISBN（列印） | 9780123978332 |
| DOIs | |
| 出版狀態 | 已發佈 - 2012 |
| 對外發佈 | Yes |
指紋
Doxorubicin
Cardiotoxicity
ASJC Scopus subject areas
- Dentistry(all)
- Medicine(all)
引用此文
Lyu, Y. L., & Liu, L-F. (2012). Doxorubicin Cardiotoxicity Revisited: Ros Versus Top2. 於 Recent Advances in Cancer Research and Therapy (頁 351-369). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-397833-2.00013-3
Doxorubicin Cardiotoxicity Revisited : Ros Versus Top2. / Lyu, Yi Lisa; Liu, Leroy-Fong.
Recent Advances in Cancer Research and Therapy. Elsevier Inc., 2012. p. 351-369.研究成果: 書貢獻/報告類型 › 章節
Lyu, YL & Liu, L-F 2012, Doxorubicin Cardiotoxicity Revisited: Ros Versus Top2. 於 Recent Advances in Cancer Research and Therapy. Elsevier Inc., 頁 351-369. https://doi.org/10.1016/B978-0-12-397833-2.00013-3
Lyu YL, Liu L-F. Doxorubicin Cardiotoxicity Revisited: Ros Versus Top2. 於 Recent Advances in Cancer Research and Therapy. Elsevier Inc. 2012. p. 351-369 https://doi.org/10.1016/B978-0-12-397833-2.00013-3
@inbook{e1a5a713dd14463ebd518ffca82b4509,
title = "Doxorubicin Cardiotoxicity Revisited: Ros Versus Top2",
author = "Lyu, {Yi Lisa} and Leroy-Fong Liu",
year = "2012",
doi = "10.1016/B978-0-12-397833-2.00013-3",
language = "English",
isbn = "9780123978332",
pages = "351--369",
booktitle = "Recent Advances in Cancer Research and Therapy",
publisher = "Elsevier Inc.",
}
TY - CHAP
T1 - Doxorubicin Cardiotoxicity Revisited
T2 - Ros Versus Top2
AU - Lyu, Yi Lisa
AU - Liu, Leroy-Fong
PY - 2012
Y1 - 2012
UR - http://www.scopus.com/inward/record.url?scp=84882491259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84882491259&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-397833-2.00013-3
DO - 10.1016/B978-0-12-397833-2.00013-3
M3 - Chapter
AN - SCOPUS:84882491259
SN - 9780123978332
SP - 351
EP - 369
BT - Recent Advances in Cancer Research and Therapy
PB - Elsevier Inc.
ER -